Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study

Shimada, Kanane; Matsumoto, Koji; Mimura, Takashi; Ishikawa, Tetsuya; Munechika, Jiro; Ohgiya, Yoshimitsu; Kushima, Miki; Hirose, Yusuke; Asami, Yuka; Iitsuka, Chiaki; Miyamoto, Shingo; Onuki, Mamiko; Tsunoda, Hajime; Matsuoka, Ryu; Ichizuka, Kiyotake; Sekizawa, Akihiko

doi:10.1007/s10147-017-1222-y

Cited by 15 publications

(14 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several reports have found that magnetic resonance imaging (MRI), alone or in combination with computed tomography (CT), predicts accurately the presence of peritoneal carcinomatosis in patients undergoing preoperative evaluation for cytoreductive surgery, particularly when the assessment is carried out by an experienced radiologist 114–117 . Recently, a prospective study reported higher specificity of the IOTA LR2 model compared with subjective interpretation of MRI findings by an experienced radiologist, as well as similar sensitivities for both imaging modalities for discriminating between benign and malignant tumors 118 . The addition of diffusion‐weighted techniques to conventional imaging modalities has been shown in multiple pooled studies to increase diagnostic accuracy in discriminating between benign tumors and ovarian cancer, especially in the Caucasian population, with data even suggesting a value in predicting resectability 119–123 .…”

Section: Resultsmentioning

confidence: 99%

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

Timmerman

Bourne

Landolfo

et al. 2021

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the preoperative diagnosis of ovarian tumors, including imaging techniques, biomarkers and prediction models.ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the preoperative diagnosis of ovarian tumors and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised.Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements.This Consensus Statement presents these ESGO/ ISUOG/IOTA/ESGE statements on the preoperative diagnosis of ovarian tumors and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.

show abstract

Section: Resultsmentioning

confidence: 99%

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

Timmerman

Bourne

Landolfo

et al. 2021

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

show abstract

“…[114][115][116][117] Recently, a prospective study reported higher specificity of the IOTA LR2 model compared with subjective interpretation of MRI findings by an experienced radiologist, as well as similar sensitivities for both imaging modalities for discriminating between benign and malignant tumors. 118 The addition of diffusion-weighted techniques to conventional imaging modalities has been shown in multiple pooled studies to increase diagnostic accuracy in discriminating between benign tumors and ovarian cancer, especially in the Caucasian population, with data even suggesting a value in predicting resectability. [119][120][121][122][123] However, the true extent of such a benefit needs to be validated further in multicenter large-scale prospective randomized studies, which are currently being designed or underway.…”

Section: Tumor Markersmentioning

confidence: 99%

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

Timmerman

Planchamp

Bourne

et al. 2021

Int J Gynecol Cancer

View full text Add to dashboard Cite

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group, and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the pre-operative diagnosis of ovarian tumors, including imaging techniques, biomarkers, and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the pre-operative diagnosis of ovarian tumors and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the pre-operative diagnosis of ovarian tumors and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.

show abstract

“…Recently, a prospective study reported higher specificity of the IOTA LR2 model compared with subjective interpretation of MRI findings by an experienced radiologist, as well as similar sensitivities for both imaging modalities for discriminating between benign and malignant tumours (Shimada et al, 2018). The addition of diffusion-weighted techniques to conventional imaging modalities has been shown in multiple pooled studies to increase diagnostic accuracy in discriminating between benign tumours and ovarian cancer, especially in the Caucasian population, with data even suggesting a value in predicting resectability (Dai et al, 2019;Espada et al, 2013;Meng et al, 2016;Michielsen et al, 2017;Rizzo et al, 2020).…”

Section: Magnetic Resonance Imagingmentioning

confidence: 99%

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours

Timmerman¹,

Bourne²,

Landolfo³

et al. 2021

Facts Views Vis ObGyn

View full text Add to dashboard Cite

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the preoperative diagnosis of ovarian tumours, including imaging techniques, biomarkers and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the preoperative diagnosis of ovarian tumours and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the preoperative diagnosis of ovarian tumours and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.

show abstract

Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study

Cited by 15 publications

References 12 publications

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours

Contact Info

Product

Resources

About